OPEC+ Meeting: Key members of OPEC+ are meeting to discuss production policy amid concerns of a global supply glut that could impact prices, although current inventory data does not yet reflect excess supply.
Production Cuts Unwound: The organization has agreed to fully unwind 2.2 million barrels a day of voluntary cuts ahead of schedule and is expected to maintain its current policy while assessing future actions in a challenging economic environment.
UBS
$42.89+Infinity%1D
Analyst Views on UBS
Wall Street analysts forecast UBS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UBS is 44.00 USD with a low forecast of 37.37 USD and a high forecast of 51.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast UBS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UBS is 44.00 USD with a low forecast of 37.37 USD and a high forecast of 51.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
3 Hold
3 Sell
Hold
Current: 43.210
Low
37.37
Averages
44.00
High
51.70
Current: 43.210
Low
37.37
Averages
44.00
High
51.70
Morgan Stanley
Underweight
maintain
2025-11-24
Reason
Morgan Stanley
Price Target
2025-11-24
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on UBS to CHF 30 from CHF 28 and keeps an Underweight rating on the shares.
Keefe Bruyette
Market Perform -> Underperform
downgrade
2025-11-07
Reason
Keefe Bruyette
Price Target
2025-11-07
downgrade
Market Perform -> Underperform
Reason
Keefe Bruyette downgraded UBS to Underperform from Market Perform with a price target of CHF 31, down from CHF 32. The firm sees regulatory pressure in Switzerland and litigation uncertainty weighing on the shares.
BNP Paribas Exane
Outperform -> Neutral
downgrade
$32
2025-11-04
Reason
BNP Paribas Exane
Price Target
$32
2025-11-04
downgrade
Outperform -> Neutral
Reason
BNP Paribas Exane downgraded UBS to Neutral from Outperform with a CHF 32 price target.
Citi
Neutral
maintain
2025-11-03
Reason
Citi
Price Target
2025-11-03
maintain
Neutral
Reason
Citi raised the firm's price target on UBS to CHF 34 from CHF 31.80 and keeps a Neutral rating on the shares.
About UBS
UBS Group AG is a Switzerland-based holding company and conducts its operations through UBS AG and its subsidiaries. The company operates as a wealth manager with focused asset management and investment banking capabilities and a capital-light and cash-generative business model. The Company comprises four business divisions: Global Wealth Management, which provides tailored advice and solutions to its clients around the globe; Personal & Corporate Banking division provides comprehensive financial products and services to private, corporate and institutional clients in Switzerland; Asset Management division offers investment capabilities and styles across all traditional and alternative asset classes, as well as advisory support to institutions; Investment Bank provides investment advice, financial solutions and capital markets access to institutional, corporate and wealth management clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
